NCT00072709 - Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter

Enrollment

551

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

TCH346

Trial Locations (9)

Novartis USA, East Hanover

Novartis Belgium, Vilvoorde

Novartis CANADA, Dorval

Novartis France, Rueil-Malmaison

Novartis Germany, Nuremberg

Novartis Italy, Saronno

Novartis Netherlands, Arnhem

Novartis Switzerland, Bern

Novartis UK, Frimley